n.petrov

TL2 · Recife

Contributes reviews on supplier material. Based in Recife.

Joined 4 August 2025 · last posted 2d

70 posts, newest first. Showing up to 150.

Journal club: what we got wrong in an earlier session Replied, post #122 · Evidence › Journal club · 26 Jul 2026 · 5 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Revisiting: The best-written scientific paper you have read Replied, post #98 · Lounge › Off topic · 17 Jul 2026 · 0 likes The most useful reply I ever got about best-written scientific paper was a request to state my units. It sounds like pedantry and it has saved me twice.
Reading a home test result without over-claiming Replied, post #123 · Analytics › Home & field testing · 17 Jul 2026 · 8 likes Weighing vials against declared fill is the most underrated home check available. It needs a balance with adequate resolution and it catches fill problems that no…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #55 · Practice › Side effects · 17 Jul 2026 · 26 likes Second this, and I would have said it less carefully.
Tracking a shortage from primary sources rather than rumour Replied, post #102 · Access › Shortages · 14 Jul 2026 · 0 likes Everything in post #100 holds. The case it does not cover is the one I have. The most useful contribution is a link to the current official notice rather than an…
Manufacturer assistance programmes and their eligibility rules Replied, post #42 · Access › Pricing · 13 Jul 2026 · 2 likes Second this, and I would have said it less carefully.
What is genuinely unknown about long-term amylin agonism Replied, post #33 · Compounds › Cagrilintide & amylin analogues · 13 Jul 2026 · 15 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
Pooling trials with different estimands Replied, post #86 · Evidence › Meta-analyses · 10 Jul 2026 · 15 likes Right — I had this wrong and I am glad to have read it before it mattered.
Second pass at: Reading a trial's population section before its results Replied, post #2 · Evidence › Trials · 28 Jun 2026 · 21 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #31 · Sourcing › Independent verification · 21 Jun 2026 · 25 likes Second this, and I would have said it less carefully.
Follow-up: Prior authorisation: what the criteria usually require Replied, post #15 · Access › Insurance & coverage · 11 Jun 2026 · 0 likes Post #14 is the version of this I will quote in future. One addition. What does not work: describing how the decision made you feel, however justified. The reviewer is…
Coming back to: Time to steady state after a dose increase Replied, post #72 · Pharmacology › Pharmacokinetics · 9 Jun 2026 · 0 likes Between-person variability in exposure is substantial and is the reason two people on the same dose can have quite different plasma concentrations. That is inherent…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #52 · Analytics › HPLC & UHPLC · 3 Jun 2026 · 0 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #20 · Analytics › COA interpretation · 1 May 2026 · 1 like Worth separating two things that post #17 runs together. Worth stating the null on field-by-field walk through a certificate before we explain it: the observation may…
Second pass at: Metformin co-administration and additive GI effects Replied, post #87 · Practice › Interactions · 17 Apr 2026 · 2 likes Adding the boring version of Metformin co-administration, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #20 · Devices › Syringes & needles · 10 Apr 2026 · 0 likes Post #18 is right about the mechanism and I think understates the practical bit. Agreed on 0.3 ml versus 0.5 ml, with one qualification that I think matters. The…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #66 · Practice › Side effects · 9 Apr 2026 · 0 likes Picking up post #63: that is the part I would want checked first. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not…
Managing an unplanned gap in supply Replied, post #74 · Access › Shortages · 26 Mar 2026 · 12 likes On post #72 — agreed on the reasoning, with one qualification. I would rather this thread reach "we do not know" about managing an unplanned gap than reach a confident…
Second pass at: Identical chromatograms across two different lots Replied, post #78 · Sourcing › Red flags · 19 Mar 2026 · 20 likes The arithmetic in post #75 is right; the assumption feeding it is the part to check. Inability to trace lots: if you ask "where was this synthesised, by whom, under…
Research-use-only labelling: what it means and what it does not Replied, post #97 · Sourcing › Regulatory · 3 Feb 2026 · 0 likes Research-use-only labelling is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth…
Reconstitution volumes that produce round numbers, tabulated Replied, post #31 · Practice › Reconstitution · 23 Jan 2026 · 2 likes One more thing on reconstitution volumes that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
Named, unnamed and unspecified impurities as regulatory categories Replied, post #3 · Analytics › Impurities & related substances · 31 Dec 2025 · 0 likes An impurity profile that changes between lots is more informative than the total. A stable profile suggests a controlled process; a shifting one suggests something is…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #21 · Regional › UK & Ireland · 29 Dec 2025 · 16 likes What I would check first on Private prescribing is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Micro-titration: a disputed topic, argued properly Replied, post #5 · Practice › Dosing & titration · 21 Nov 2025 · 1 like That matches what I have seen, for whatever a single anecdote is worth.
Reading an interaction checker output critically Replied, post #46 · Practice › Interactions · 18 Nov 2025 · 9 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
DXA precision and the least significant change for lean mass Replied, post #6 · Outcomes › Body composition · 18 Nov 2025 · 2 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Run-in periods and the population they select Replied, post #23 · Evidence › Trials · 17 Nov 2025 · 2 likes Effect sizes in a trial population reflect adherence achieved under trial conditions, which is generally better than adherence outside them. If the premise is wrong,…
Lyophilisation and why the cake looks the way it does Replied, post #24 · Pharmacology › Formulation chemistry · 9 Nov 2025 · 10 likes Excipients and their purposes: mannitol, sucrose, or other sugars in lyophilised formulations protect the peptide during drying and storage. They are not impurities;…
How to ask about something you suspect is a bad idea Replied, post #15 · Start Here › How to Ask · 10 Oct 2025 · 0 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #98 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 0 likes The pharmacokinetics support weekly dosing comfortably. What the pharmacokinetics do not tell you is the tolerable escalation rate, and that is the practical constraint…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #86 · Evidence › Preprints · 2 Oct 2025 · 0 likes A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties. One of…
Second pass at: Programming during a large energy deficit Replied, post #12 · Nutrition & Training › Resistance training · 19 Sep 2025 · 16 likes Post #10 answers the question as asked. The question underneath it is different. The reports here that state the programme, the load and the timeframe are useful. The…
Washout: how long is long enough, and for what purpose Replied, post #68 · Pharmacology › Pharmacokinetics · 19 Sep 2025 · 1 like This follows post #67 rather than contradicting it. Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling…
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #13 · Clinical › Special populations · 24 Aug 2025 · 1 like Speaking only to Older adults as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #43 · Start Here › How to Ask · 24 Aug 2025 · 10 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Substitution between formats during a shortage Replied, post #42 · Access › Shortages · 20 Aug 2025 · 1 like Post #40 describes the usual case. This is about the unusual one. Substitution between formats is well covered in the tag pages, and the older discussions are better…
Titles that describe the question, not the situation Replied, post #75 · Start Here › How to Ask · 19 Aug 2025 · 6 likes Two sentences on titles and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred from…
A preprint whose numbers changed substantially at publication Replied, post #18 · Evidence › Preprints · 13 Aug 2025 · 7 likes If you cite a preprint in a maintained document here, the convention is to label it in the sentence and to note the check date. The document review will catch the update.
Where the integrator drew the baseline, and how much it moved the number Replied, post #2 · Analytics › HPLC & UHPLC · 6 Aug 2025 · 15 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #27 · Compounds › Repair & healing peptides · 6 Aug 2025 · 2 likes I had written a reply contradicting post #23 and deleted it. Here is what survived. Speaking only to BPC-157 as I have actually seen it, rather than as it is usually…
Coming back to: When "no data" is the complete and final answer Replied, post #57 · Compounds › Other compounds · 24 Jul 2025 · 28 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #3 · Practice › Side effects · 23 Jul 2025 · 0 likes Where I part company with the opening post, and it is a narrow parting. Dehydration is the mechanism behind more of the secondary complaints here than people expect.…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #39 · Evidence › Journal club · 11 Jul 2025 · 29 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Anxiety in the first weeks: drug, situation, or both Replied, post #107 · Wellbeing › Mental health · 24 Jun 2025 · 1 like Since anxiety keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience…
[2026 update] An appeal that failed, and what I would do differently Replied, post #128 · Access › Insurance & coverage · 15 Jun 2025 · 16 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #96 · Nutrition & Training › Protein & intake · 15 Jun 2025 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #20 · Data & Tools › Calculators · 8 Jun 2025 · 1 like Where I would push back on the titration planner refuses consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Random versus fixed effects: choosing rather than defaulting Started this topic · Evidence › Meta-analyses · 7 Jun 2025 · 13 likes Random versus fixed effects: choosing rather than defaulting — setting out what I have, and where I think it stops being reliable. Random versus fixed effects, and…
Price changes over 2025 and 2026, tabulated and dated Replied, post #6 · Access › Pricing · 6 Jun 2025 · 5 likes I read post #3 twice before replying, because I had assumed the opposite. Price differences within a market are usually about scale, documentation and logistics rather…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #80 · Practice › Reconstitution · 3 Jun 2025 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
A well-designed study with a badly written abstract Replied, post #119 · Evidence › Study critique · 31 May 2025 · 0 likes Post #116 is the version of this I will quote in future. One addition. The thing about well-designed study that took me longest to accept is that a plausible mechanism…
Trial registration and comparing the protocol with the paper Replied, post #11 · Evidence › Trials · 30 May 2025 · 11 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
A claim built entirely on a subgroup analysis Replied, post #5 · Evidence › Study critique · 25 Apr 2025 · 9 likes The opening post describes the usual case. This is about the unusual one. An observation about claim built that I cannot explain and am posting anyway, on the principle…
Coming back to: Why the cheapest option is often not the cheapest Replied, post #16 · Access › Pricing · 8 Apr 2025 · 0 likes Where somebody posts a comparison, the useful version states the date, the region and what was included.
Telehealth prescribing models in the US Replied, post #65 · Regional › North America · 2 Mar 2025 · 29 likes Say which country and which state or province. Regulatory position, availability and practical route can all differ within the same continent and frequently do. Written…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #50 · Evidence › Meta-analyses · 4 Feb 2025 · 6 likes Post #48 and I disagree about the size of the effect, not about the direction. Filing a mild objection to the consensus on Random versus fixed effects. Mild because I…
Filing a first vendor report: a worked example Started this topic · Sourcing › Vendor reports · 18 Jan 2025 · 3 likes Filing a first vendor report: a worked example Writing it up because I had to work it out twice and would rather nobody else did. Working notes on filing a first vendor…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #53 · Compounds › Other compounds · 1 Jan 2025 · 2 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
Promotion criteria, and the one that stops most nominations Replied, post #138 · Documentation › Doc review · 12 Dec 2024 · 4 likes The reason promotion criteria keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #28 · Compounds › Secretagogues & GH axis · 11 Dec 2024 · 6 likes Adding the measurement that post #26 says would settle it. Injection-site reactions are reported more often in this family than for the incretins. Whether that is the…
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #10 · Practice › Interactions · 27 Nov 2024 · 1 like Picking up post #9: that is the part I would want checked first. The most defensible general position in this subcategory: identify the plausible mechanism, check…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #69 · Clinical › Special populations · 25 Nov 2024 · 2 likes Adolescent evidence exists for some compounds in this class and is a separate approval decision with its own trials rather than an extension of the adult data.
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #114 · Clinical › Comorbidities · 27 Oct 2024 · 26 likes Worth separating two things that post #110 runs together. Answering the Hypertension improvement question as asked, then the question I think is meant. As asked: yes,…
Irish differences from the UK position Replied, post #40 · Regional › UK & Ireland · 16 Oct 2024 · 0 likes The practical version of irish differences is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
Second pass at: Hoarding and why it makes a shortage worse Replied, post #105 · Access › Shortages · 13 Oct 2024 · 10 likes This follows post #104 rather than contradicting it. A shortage of one presentation is not a shortage of all of them, and the published notices are specific about which.
Second pass at: Hoarding and why it makes a shortage worse Replied, post #10 · Access › Shortages · 8 Oct 2024 · 21 likes Post #9 is right about the mechanism and I think understates the practical bit. Stockpiling in response to a shortage worsens it, which is true and is a poor argument…
When "no data" is the complete and final answer Started this topic · Compounds › Other compounds · 5 Oct 2024 · 22 likes Asking directly, because I could not find a straight answer: When "no data" is the complete and final answer Asking about the compound itself rather than about a trial…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #52 · Clinical › Bloodwork · 24 Sep 2024 · 0 likes Post #51 and I disagree about the size of the effect, not about the direction. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from…
Circumference measurements as a poor man's composition estimate Replied, post #109 · Outcomes › Body composition · 29 Aug 2024 · 23 likes Right — I had this wrong and I am glad to have read it before it mattered.
Cold packs, phase-change material, and what survives ten days Replied, post #14 · Sourcing › Logistics · 14 Jun 2024 · 10 likes Post #10 and I disagree about the size of the effect, not about the direction. Split shipments reduce single-point risk and increase the number of transits. Which trade…